Laurion Capital Management LP
About Laurion Capital Management LP’s 13F portfolio
Laurion Capital Management LP is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Laurion Capital Management LP reported $1.4B across 253 US-listed positions (). Its largest position is STATE STR SPDR S&P 500 ETF T (SPY) at 15% of the reported book, and its ten biggest holdings make up 63% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NYSE Arca: SPY STATE STR SPDR S&P 500 ETF T | — — | 15% | 270K | $201.6M |
| 2 | NYSE: NSC NORFOLK SOUTHN CORP | — — | 8.8% | 384K | $120.9M |
| 3 | NASDAQ: EA ELECTRONIC ARTS INC | — — | 8.4% | 564K | $115.6M |
| 4 | NASDAQ: WBD WARNER BROS DISCOVERY INC | — — | 7.6% | 3.9M | $104.9M |
| 5 | NASDAQ: BBIO BRIDGEBIO PHARMA INC | — — | 7.3% | 1.4M | $100.7M |
| 6 | NYSE: DLR DIGITAL RLTY TR INC | — — | 5.0% | 387K | $69.4M |
| 7 | NASDAQ: MLYS MINERALYS THERAPEUTICS INC | — — | 4.9% | 2.5M | $67.6M |
| 8 | NYSE: NUVB NUVATION BIO INC | — — | 3.2% | 7.8M | $44.4M |
| 9 | NASDAQ: QCOM QUALCOMM INC | — — | 1.7% | 128K | $23.6M |
| 10 | NASDAQ: BBIO BRIDGEBIO PHARMA INC | — — | 1.5% | 19.1M | $21.2M |
| 11 | NASDAQ: KTOS KRATOS DEFENSE & SEC SOLUTIO | — — | 1.3% | 357K | $17.8M |
| 12 | — NIO INC | — — | 1.3% | 17.5M | $17.5M |
| 13 | NYSE: FPS FORGENT POWER SOLUTIONS INC | — — | 1.2% | 294K | $16.4M |
| 14 | NASDAQ: INIO INNIO NV | — — | 1.1% | 400K | $15.8M |
| 15 | — NIO INC | — — | 1.1% | 15.5M | $15.5M |
| 16 | NASDAQ: BBOT BRIDGEBIO ONCOLOGY THERAPEUT | — — | 1.1% | 2.0M | $15.3M |
| 17 | NASDAQ: PYXS PYXIS ONCOLOGY INC | — — | 1.1% | 4.9M | $14.8M |
| 18 | NASDAQ: MDLN MEDLINE INC | — — | 1.0% | 349K | $13.8M |
| 19 | NASDAQ: MSFT MICROSOFT CORP | — — | 0.9% | 35K | $13.0M |
| 20 | NYSE: CVNA CARVANA CO | — — | 0.9% | 190K | $12.5M |
| 21 | NASDAQ: CEG CONSTELLATION ENERGY CORP | — — | 0.9% | 48K | $11.9M |
| 22 | NYSE: DHI D R HORTON INC | — — | 0.8% | 68K | $11.0M |
| 23 | NYSE: ABBV ABBVIE INC | — — | 0.8% | 42K | $10.6M |
| 24 | NASDAQ: CME CME GROUP INC | — — | 0.7% | 47K | $10.3M |
| 25 | NASDAQ: HOOD ROBINHOOD MKTS INC | — — | 0.7% | 99K | $9.9M |
Showing 1–25 of 253 positions on this page reported in this 13F.
- Healthcare25%
- Communication Services17%
- Industrials12%
- Technology7.8%
- Real Estate5.1%
- Consumer Cyclical4.2%
- Financial Services3.3%
- Energy1.6%
- Basic Materials1.3%
- Utilities1.2%
- Consumer Defensive0.9%
- NewSPYSTATE STR SPDR S&P 500 ETF T—$201.6M
- AddedNSCNORFOLK SOUTHN CORP+9.3%$120.9M
- AddedWBDWARNER BROS DISCOVERY INC+26.5%$104.9M
- AddedBBIOBRIDGEBIO PHARMA INC+7.1%$100.7M
- NewDLRDIGITAL RLTY TR INC—$69.4M
- AddedMLYSMINERALYS THERAPEUTICS INC+12.3%$67.6M
- NewQCOMQUALCOMM INC—$23.6M
- AddedKTOSKRATOS DEFENSE & SEC SOLUTIO+58.6%$17.8M
- NewINIOINNIO NV—$15.8M
- AddedBBOTBRIDGEBIO ONCOLOGY THERAPEUT+4.2%$15.3M
- ReducedEAELECTRONIC ARTS INC−0.6%$115.6M
- ReducedNUVBNUVATION BIO INC−0.0%$44.4M
- ReducedFPSFORGENT POWER SOLUTIONS INC−58.0%$16.4M
- ReducedPYXSPYXIS ONCOLOGY INC−1.9%$14.8M
- ReducedMETAMETA PLATFORMS INC−30.6%$6.0M
- ReducedAVGOBROADCOM INC−25.1%$5.6M
- ReducedBOBSBOBS DISC FURNITURE INC−33.3%$4.7M
- ReducedSNDKSANDISK CORP−68.0%$3.8M
- ReducedLNGCHENIERE ENERGY INC−45.0%$3.7M
- ReducedFERGFERGUSON ENTERPRISES INC−53.9%$2.8M
Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.
| # | Stock | Type | % of class | Shares | Filed |
|---|---|---|---|---|---|
| 1 | PYXS Pyxis Oncology, Inc. | 13G | 7.7% · 2 classes | 4.8M | Filed 09 FEB 2026 |
Showing all 1 disclosed stakes.
Reading Laurion Capital Management LP’s 13F portfolio
Laurion Capital Management LP’s $1.4B 13F book is spread across 253 reported positions and is highly concentrated — its ten largest positions alone are 63% of the portfolio. A book this concentrated means a small group of names drives most of its performance. Its five largest positions are SPY, NSC, EA, WBD and BBIO, led by STATE STR SPDR S&P 500 ETF T (SPY) at 15% of the portfolio. The heaviest sector exposure is Healthcare (25%), then Communication Services (17%).
What Laurion Capital Management LP changed last quarter
Between 2026-03-31 and Q2 2026, Laurion Capital Management LP was a net buyer: it opened 158 new positions and added to 35 more, while trimming 48 and closing 94 outright. Against a 253-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was STATE STR SPDR S&P 500 ETF T (SPY), and its biggest reduction was ELECTRONIC ARTS INC (EA).
What a 13F does and doesn’t reveal
A 13F captures only Laurion Capital Management LP’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Laurion Capital Management LP is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Laurion Capital Management LP's profile on this page is built directly from those filings.
How current is the 13F data on Laurion Capital Management LP's page?
It reflects Laurion Capital Management LP's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Laurion Capital Management LP files its next quarterly report, this page refreshes automatically.
Can I see Laurion Capital Management LP's complete list of holdings?
This page highlights Laurion Capital Management LP's largest positions rather than all 253 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Laurion Capital Management LP's filings.
Does a 13F show everything Laurion Capital Management LP owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Laurion Capital Management LP's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Laurion Capital Management LP made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

